Trunk mutational events present minimal intra- and inter-tumoral heterogeneity in hepatocellular carcinoma

被引:111
|
作者
Torrecilla, Sara [1 ,2 ]
Sia, Daniela [1 ]
Harrington, Andrew N. [1 ,3 ]
Zhang, Zhongyang [4 ,5 ]
Cabellos, Laia [2 ]
Cornella, Helena [2 ]
Moeini, Agrin [2 ]
Camprecios, Genis [1 ]
Leow, Wei-Qiang [1 ,6 ]
Fiel, Maria Isabel [1 ]
Hao, Ke [4 ,5 ]
Bassaganyas, Laia [2 ]
Mahajan, Milind [1 ]
Thung, Swan N. [1 ]
Villanueva, Augusto [1 ]
Florman, Sander [1 ]
Schwartz, Myron E. [1 ]
Llovet, Josep M. [1 ,2 ,7 ]
机构
[1] Icahn Sch Med Mt Sinai, Recanati Miller Transplantat Inst, Tisch Canc Inst,Dept Pathol, Mt Sinai Liver Canc Program,Div Liver Dis,Dept Med, New York, NY 10029 USA
[2] Univ Barcelona, Hosp Clin, Liver Unit, Liver Canc Translat Res Lab,BCLC Grp,IDIBAPS, Barcelona, Catalonia, Spain
[3] Mt Sinai West St Lukes, Dept Surg, Residency Program, New York, NY USA
[4] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA
[5] Icahn Sch Med Mt Sinai, Icahn Inst Genom & Multiscale Biol, New York, NY 10029 USA
[6] Singapore Gen Hosp, Dept Anat Pathol, Singapore, Singapore
[7] Inst Catalana Recerca & Estudis Avancats, Barcelona, Catalonia, Spain
关键词
Liver cancer; Gatekeeper; Driver; Tumor evolution; Clonality; SORAFENIB; LANDSCAPE; EVOLUTION; LESIONS;
D O I
10.1016/j.jhep.2017.08.013
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: According to the clonal model of tumor evolution, trunk alterations arise at early stages and are ubiquitous. Through the characterization of early stages of hepatocarcinogenesis, we aimed to identify trunk alterations in hepatocellular carcinoma (HCC) and study their intra- and inter-tumor distribution in advanced lesions. Methods: A total of 151 samples representing the multistep process of hepatocarcinogenesis were analyzed by targeted-sequencing and a single nucleotide polymorphism array. Genes altered in early lesions (31 dysplastic nodules [DNs] and 38 small HCCs [sHCC]) were defined as trunk. Their distribution was explored in: a) different regions of large tumors (43 regions, 21 tumors), and b) different nodules of the same patient (39 tumors, 17 patients). Multinodular lesions were classified as intrahepatic metastases (IMs) or synchronous tumors based on chromosomal aberrations. Results: TERT promoter mutations (10.5%) and broad copy-number aberrations in chromosomes 1 and 8 (3-7%) were identified as trunk gatekeepers in DNs and were maintained in sHCCs. Trunk drivers identified in sHCCs included TP53 (23%) and CTNNB1 (11%) mutations, and focal amplifications or deletions in known drivers (6%). Overall, TERT, TP53 and CTNNB1 mutations were the most frequent trunk events and at least one was present in 51% of sHCCs. Around 90% of mutations in these genes were ubiquitous among different regions of large tumors. In multinodular HCCs, 35% of patients harbored IMs; 85% of mutations in TERT, TP53 and/or CTNNB1 were retained in primary and metastatic tumors. Conclusions: Trunk events in early stages ( TERT, TP53, CTNNB1 mutations) were ubiquitous across different regions of the same tumor and between primary and metastatic nodules in > 85% of cases. This concept supports the knowledge that single biopsies would suffice to capture trunk mutations in HCC. (C) 2017 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:1222 / 1231
页数:10
相关论文
共 13 条
  • [2] Testing HepatoPredict kit performance in liver transplantation prognosis for hepatocellular carcinoma when facing intra- and inter-tumoral heterogeneity
    Cardoso, J.
    Proenca, D.
    Caetano Oliveira, R.
    Frazao, L.
    Andrade, R.
    Goncalves-Reis, M.
    Neto, J. L.
    Pereira-Leal, J. B.
    Tralhao, J. G.
    [J]. TRANSPLANTATION, 2023, 107 (09) : 138 - 138
  • [3] High Intra- and Inter-Tumoral Heterogeneity of RAS Mutations in Colorectal Cancer
    Jeantet, Marion
    Tougeron, David
    Tachon, Gaelle
    Cortes, Ulrich
    Archambaut, Celine
    Fromont, Gaelle
    Karayan-Tapon, Lucie
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (12)
  • [4] High intra- and inter-tumoral heterogeneity of RAS mutations in colorectal cancer.
    Tougeron, David
    Jeantet, Marion
    Cortes, Ulrich
    Archambaut, Celine
    Fromont, Gaelle
    Tourani, Jean-Marc
    Karayan-Tapon, Lucie
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [5] MEDULLOBLASTOMA TUMOR MICROENVIRONMENTS SHOW INTRA- AND INTER-TUMORAL HETEROGENEITY ON SPATIAL TRANSCRIPTOMICS
    Chien, Franklin
    Michaud, Marina
    Bakhtiari, Mojtaba
    Ross, James L.
    Schroff, Chanel
    Snuderl, Matija
    MacDonald, Tobey
    Bhasin, Manoj
    [J]. NEURO-ONCOLOGY, 2024, 26
  • [6] DISSECTING THE INTRA- AND INTER-TUMORAL HETEROGENEITY UNDERLYING GLIOBLASTOMA PATHOGENESIS UTILIZING MULTI-OMICS ANALYSIS
    Nakashima, Takuma
    Funakoshi, Yusuke
    Yajima, Hirohisa
    Yamamoto, Ryo
    Sugihara, Yuriko
    Nambu, Shohei
    Arakawa, Yoshiki
    Tanaka, Shota
    Ishida, Joji
    Saito, Ryuta
    Hanaya, Ryosuke
    Yoshimoto, Koji
    Narita, Yoshitaka
    Suzuki, Hiromichi
    [J]. NEURO-ONCOLOGY, 2023, 25
  • [7] Intra- and Inter-Tumoral Homogeneity of BRAFV600E Mutations in Melanoma Tumors
    Riveiro-Falkenbach, Erica
    Villanueva, Candida A.
    Garrido, Maria C.
    Ruano, Yolanda
    Garcia-Martin, Rosa M.
    Godoy, Elena
    Ortiz-Romero, Pablo L.
    Rios-Martin, Juan J.
    Santos-Briz, Angel
    Rodriguez-Peralto, Jose L.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 (12) : 3078 - 3085
  • [8] Effect of intra- and inter-tumoral heterogeneity on molecular characteristics of primary IDH-wild type glioblastoma revealed by single-cell analysis
    Xiong, Zujian
    Yang, Qi
    Li, Xuejun
    [J]. CNS NEUROSCIENCE & THERAPEUTICS, 2020, 26 (09) : 981 - 989
  • [9] KINOMO: A non-negative matrix factorization framework for recovering intra- and inter-tumoral heterogeneity from single-cell RNA-seq data
    Tagore, Somnath
    Wang, Yiping
    Biermann, Jana
    D'Souza, Edridge K.
    Luthria, Karan D.
    Rabadan, Raul
    Azizi, Elham
    Izar, Benjamin
    [J]. CANCER RESEARCH, 2024, 84 (06)
  • [10] Dynamic changes in tumor profiling reveal intra- and inter-tumoral heterogeneity focused on an uncharacterized HER2 mutation: a case report of a young breast cancer patient
    Schaffrin-Nabe, Doerthe
    Josten-Nabe, Anke
    Tannapfel, Andrea
    Uhl, Waldemar
    Garmer, Marietta
    Kurzrock, Razelle
    Crook, Timothy
    Limaye, Sewanti
    Schuster, Stefan
    Patil, Darshana
    Schaffrin, Merle
    Mokbel, Kefah
    Voigtmann, Rudolf
    [J]. FRONTIERS IN ONCOLOGY, 2024, 14